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A panel of 4 monoclonal antibodies and 7 polyclonal antisera against NAD-dependent formate dehydrogenase from methylotrophic bacterium 
Pseudomonas sp. 101 has been obtained. The reactivity of the 37 overlapping proteolytic peptides with the monoclonal antibodies and polyclonal 
antisera has been studied with ELISA test. The data obtained were interpreted residing on the structural model of the formate dehydrogenase 
at 3 A resolution. The immunodominant regions in the formate dehydrogenase molecule and the epitopes for the monoclonal antibodies were 
elucidated. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
The study of the antigenic structures contributes to 
the understanding of the protein-protein interactions 
[l-4], constructing of synthetic vaccines [5,6], detecting 
gene products and isolating proteins [7]. In spite of re- 
cent advances in the elucidation of the factors essential 
for antigenicity [3,4,8-l I], there still remains some con- 
troversy concerning the molecular mechanism of 
antigen-antibody recognition. The database on the 
complexes between protein antigens and antibodies is 
restricted now to only a few structures [1,2,12-141 and 
the need for expanding on it seems rather urgent. 
2.1. Preparation of peptides 
Formate dehydrogenase was purified by a standard procedure [15]. 
To obtain a set of overlapping peptides, the formate dehydrogenase 
was digested at lysine, arginine and glutamate residues by specific pro- 
teases [15]. In some cases, longer peptides originating from the BrCN 
cleavage at methionine residues were used. Peptides were purified by 
a double or triple HPLC using gel-filtration and Cs columns. Purity 
of the peptides was verified by amino acid analysis or direct sequenc- 
ing as described earlier [15]. 
About 7% of the amino acid sequence of the formate 
dehydrogenase was not tested for the antigen properties because of 
the low yields or insufficient length of the corresponding peptides. 
2.2. Monoclonal antibodies and polyclonal antisera 
NAD-dependent formate dehydrogenase from 
methylotrophic bacterium Pseudomonas sp. 101 is a 
dimer (MI -86 000) composed of two identical 
subunits. This protein has been recently sequenced and 
its tertiary structure at 3 A resolution resolved [15-171. 
Polyclonal antibodies were obtained by immunization of BALB/c 
mice with formate dehydrogenase according to 7 different immuniza- 
tion protocols. 
Here we report the first experiments on the antigenic 
properties of formate dehydrogenase. Polyclonal an- 
tisera have been used for mapping the immunodomi- 
nant regions in the protein molecule. A panel of 4 
monoclonal antibodies against the native formate 
dehydrogenase has also been obtained and their cor- 
responding epitopes elucidated. Structural models of 
the enzyme was used for the spatial presentation of the 
immunological studies. 
Four hybridoma cell lines were obtained by fusion of the immune 
mice splenocytes with the Sp2/0 myeloma cell line by a standard pro- 
cedure [18]. Monoclonal antibodies were purified by affinity 
chromatography on immobilized formate dehydrogenase. 
2.3. ELISA 
From 10 to 80 (usually 20-30) pmol of the peptide was applied to 
the nitrocellulose filter strip. The strips were blocked with 5 mg/ml 
BSA/0.3% Tween-20 for 1 h followed by a thorough rinsing in 0.01 
M Na-phosphate buffer, pH 7.4, containing 0.15 M NaCl and 0.3% 
Tween-20 (PBS). Then the strips were incubated in the antibody solu- 
tion for 1 h, rinsed and incubated in the solution containing conjugate 
of peroxidase with rabbit anti-mouse antibodies for another 1 h. After 
rinsing, the nitrocellulose strips were developed in the substrate mix- 
ture of 0.5 mg/ml diaminobenzidine/0.02% CoC12/30% Hz02 (15 
pl/lOO ml) in PBS. 
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2.4. Structural model of the formate dehydrogenase 
Recently the three-dimensional structure of formate dehydrogenase 
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at 3 A resolution was elucidated and the fold of the main chain was 
determined [16]. In this work we used nonrefined coordinates of the 
main chain atoms (unpublished ata). A novel method of ‘molecular 
cartography’ [19] was used to visualize the results of immunochemical 
studies. 
3. RESULTS AND DISCUSSION 
3.1. Visualisation of the results 
In accordance with [19], the formate dehydrogenase 
molecule was approximated by an ellipsoid. The 
semiaxes were fitted out as 33, 50 and 31 A. The areas 
including superficial amino acid residues were projected 
on the surface of the ellipsoid. Only the residues form- 
ing part of the ‘positive’ tested peptides were taken into 
consideration. Suitable representation of im- 
munodominant regions and epitope areas as an ‘unfold- 
ed’ ellipsoid is shown in fig.lA-E. Angle increment be- 
tween meridians is 30”. As mentioned above, the for- 
mate dehydrogenase molecule is a dimer composed of 
two-identical subunits [ 161. The molecular two-fold 
symmetry axis coincludes with z-axis of molecular coor- 
dinate system xyz (see fig.lE). For more convenient 
representation only one of the epitopes is shown in 
fig. l A-D. 
3.2. Immunodominant regions 
The amino acid sequence of the formate 
dehydrogenase is presented in fig.2. The peptides used 
for the immunological studies are listed in table 1. The 
response of these peptides to the ELISA test is also 
shown in table 1. 
Comparing the peptides from table 1 with each other, 
it is possible in some cases to locate relatively short 
segments of polypeptide chain that presumably contain 
antigenic determinants of formate dehydrogenase. Of 
course, this approach reveals only the so-called sequen- 
tial determinants [20]. 
Our assignment of the potential antigenic regions in 
formate dehydrogenase molecule is based on the 
assumption that the residues contributing to the an- 
tigenic determinants should be as a rule (but not 
necessarily [4]) accessible from the solvent. Seven sites, 
residues 107-115,214-224,269-275,318-322,333-343, 
360-363 and 379-393, comprising about 16% of the 
total length of the formate dehydrogenase subunit 
emerge as immunodominant (the peptides incor- 
porating them are always positive with all the 7 antisera 
tested). Three other regions may be located with less 
confidence. These are residues 27-40, 57-61 and 85-91 
(-7%). 
The distribution of the immunodominant regions 
over formate dehydrogenase molecule is presented in 
fig. 1E. 
3.3. Epitopes for monoclonal antibodies 
The majority of the monoclonal antibodies against 
native proteins are considered to be directed against 
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Fig.1. The schematic representation of the epitope areas of the 
monoclonal antibodies (A) for Cs, (B) for Ott, (C) for G2, and(D) for 
Gte, and the immunodominant regions of the formate dehydrogenase 
(E). Molecular coordinate axes are shown. 
discontinuous conformational epitopes [2]. Assuming 
that the peptides representing contiguous parts of the 
conformational antigenic determinants will still bind to 
the respective monoclonal antibodies (but probably 
with much less affinity), we decided to try to map the 
epitopes for monoclonal antibodies on the surface of 
formate dehydrogenase. 
The additivity test showed that all the 4 antibodies 
compete for one and the same site on the protein sur- 
face. The additivity coefficient [21] varied from -7% 
for the Gio/G2 pair to 21% for Gl l/C3. Table 1 con- 
firms a low degree of additivity of the monoclonal an- 
tibodies under study. All 4 antibodies give strong 
positive reactions with at least 4 polypeptide fragments: 
residues 27-40, 56-63, 333-343 and 370-379. 
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10 20 30 40 
AKVLCVLYDDPVDGYPKTYARDDLPKIDHYPGGQTLPTPK 
50 60 70 80 
AIDFTPGQLLGSVSGELGLRKYLESNGHTLVVTSDKSGPD 
90 100 110 120 
SVFERELVDADVVISQPFWPAYLTPERIAKAKNLKLALTA 
130 140 150 160 
GIGSDHVDLQSAIDRNVVTAEVTYVNSISVAEHVVMMILS 
170 180 190 200 
LVRNYLPSHEWARKGGWNIADCVSHAYDLEAMHVGTVAAG 
210 220 230 240 
RIGLAVLRRLAPFDHVLHYTDRHRLPESVEKELNLTWHAT 
250 260 270 280 
REDMYPVCDVVTLNCPLHPETEHMINDETLKLFKRGAYIV 
290 300 310 320 
NTARGKLCDRDAVARALESGRLAGYAGDVWFPQPAPKDHP 
330 340 350 360 
WRTMPYDGMTPHISGTTLTAQARYAAGTREILECFFEGRP 
370 380 390 
IRDEYLIVQGGALAGTGAHSYSKGNATGGSEEA 
Fig.2. The amino acid sequence of formate dehydrogenase [15]. 
Table 1 
Peptide Polyclonal antisera Monoclonals 
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Inspection of the spatial model of the formate 
dehydrogenase shows that these segments of the 
polypeptide chain cluster within the limited area on the 
protein surface (fig. lA-D). It may be hypothesized that 
amino acid residues located in these segments con- 
tribute to the antigenic determinant hat is shared by all 
the antibodies obtained. 
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